Phase 2: Interventional, children 0-59 months of age for Sepsis

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
BC Children's Hospital Research Institute, Vancouver, CanadaSepsisRisk-stratified discharge and post-discharge care - Behavioral
Eligibility
No minimum age - 59
All Sexes
What conditions do you have?
Select

Study Summary

This trial seeks to reduce childhood mortality in Uganda by predicting risk of recurrent illness and providing post-discharge support.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: From discharge until 6 months post-discharge

Month 6
Post-discharge health seeking
Post-discharge mortality
Post-discharge re-admission

Trial Safety

Trial Design

2 Treatment Groups

Phase 1: Observational, children 0-59 months of age
1 of 2
Phase 2: Interventional, children 0-59 months of age
1 of 2

Active Control

Experimental Treatment

11700 Total Participants · 2 Treatment Groups

Primary Treatment: Phase 2: Interventional, children 0-59 months of age · No Placebo Group · N/A

Phase 2: Interventional, children 0-59 months of age
Behavioral
Experimental Group · 1 Intervention: Risk-stratified discharge and post-discharge care · Intervention Types: Behavioral
Phase 1: Observational, children 0-59 months of ageNoIntervention Group · 1 Intervention: Phase 1: Observational, children 0-59 months of age · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from discharge until 6 months post-discharge

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,337 Previous Clinical Trials
1,541,161 Total Patients Enrolled
12 Trials studying Sepsis
22,631 Patients Enrolled for Sepsis
WalimuOTHER
4 Previous Clinical Trials
80,562 Total Patients Enrolled
1 Trials studying Sepsis
60 Patients Enrolled for Sepsis
Mbarara University of Science and TechnologyOTHER
73 Previous Clinical Trials
52,493 Total Patients Enrolled
Grand Challenges CanadaOTHER
62 Previous Clinical Trials
83,983 Total Patients Enrolled
Thrasher Research FundOTHER
127 Previous Clinical Trials
77,570 Total Patients Enrolled
British Columbia Childrens Hospital FoundationOTHER
4 Previous Clinical Trials
125 Total Patients Enrolled
Matthew O Wiens, PharmD, PhDPrincipal InvestigatorUniversity of British Columbia
1 Previous Clinical Trials
6,700 Total Patients Enrolled
1 Trials studying Sepsis
6,700 Patients Enrolled for Sepsis

Eligibility Criteria

Age No minimum age - 59 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Participants must be older than five years of age.
References

Frequently Asked Questions

Is the sample population for this research limited to individuals aged 40 or older?

"We are looking for participants who range in age from 0 days to 59 months." - Anonymous Online Contributor

Unverified Answer

Who qualifies to be a participant in this clinical investigation?

"This trial is recruiting 117 hundred participants with sepsis, aged between 0 days and 59 months old. To be considered eligible for the study, potential patients must meet these requirements." - Anonymous Online Contributor

Unverified Answer

Are there any current opportunities to participate in this clinical experiment?

"According to the records on clinicaltrials.gov, this medical trial is currently open for recruitment and was initially posted in July of 2017, with its last update occurring in February of 2023." - Anonymous Online Contributor

Unverified Answer

How many individuals are partaking in this investigation?

"Affirmative, clinicaltrials.gov data reveals that this experiment is currently enrolling patients. The trial was first posted on July 16th 2017 and recently updated on February 14th 2023. Over 11700 participants need to be recruited from 1 medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.